Zobrazeno 1 - 10
of 74
pro vyhledávání: '"PAUL J. SCHECHTER"'
Autor:
Paul J. Schechter
Publikováno v:
The Medical Treatment of Epilepsy ISBN: 9781003066736
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b273d128ff4b77ea485c7b2e577ab118
https://doi.org/10.1201/9781003066736-37
https://doi.org/10.1201/9781003066736-37
Autor:
Roland Tubiana, Christine Katlama, Caroline Lascoux, Oliver Taulera, Aharon S. Cohen, R. Russell Martin, Christophe Tournerie, Barry Dvorchik, Andre Bourque, Paul J. Schechter, Daniel Sereni, Alain Gouyette
Publikováno v:
The Journal of Clinical Pharmacology. 39:47-54
Trecovirsen, a 25-mer antisense phosphorothioate oligonucleotide targeted at the gag site of the HIV gene, was administered to HIV-positive volunteers as an i.v. infusion. Single doses ranged from 0.1 to 2.5 mg/kg in an ascending escalation in cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b5c31df7bd9fb2fb5d4fc0aa93398b1
https://doi.org/10.1177/00912709922007552
https://doi.org/10.1177/00912709922007552
Autor:
Robert B. Diasio, Girish Amin, Ruiwen Zhang, Zhiwei Jiang, Sudhir Agrawal, Jieming Yan, Tiepu Liu, R. Russell Martin, Michael S. Saag, Zhihong Lu, Harout Shahinian, Jamal Temsamani, Paul J. Schechter
Publikováno v:
Clinical Pharmacology & Therapeutics. 58:44-53
Human pharmacokinetics of an antisense oligodeoxynucleotide phosphorothioate (GEM 91) developed as an anti—human immunodeficiency virus (HIV) agent was carried out in this study. 35S-Labeled GEM 91 was administered to six HIV-infected individuals b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d53c1adc36ffe1915b12a2768311ef8
https://doi.org/10.1016/0009-9236(95)90071-3
https://doi.org/10.1016/0009-9236(95)90071-3
Publikováno v:
Antisense Research and Development. 4:201-206
Rapid intravenous infusion of GEM 91, a 25-mer phosphorothioate oligonucleotide complementary to the gag site of HIV, in the monkey produces transient decreases in peripheral total WBC and neutrophil counts, hemoconcentration, and a brief increase fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0e5d4cc9252e63c4bc86f94d20a5cd4
https://doi.org/10.1089/ard.1994.4.201
https://doi.org/10.1089/ard.1994.4.201
Autor:
Paul J. Schechter, Kailash C. Bhol
Publikováno v:
Digestive diseases and sciences. 52(10)
Nanocrystalline silver (NPI 32101) has been demonstrated to have antimicrobial and anti-inflammatory properties. The purpose of this study was to assess the effect of NPI 32101 in a rat model of ulcerative colitis and the possible mechanisms of actio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3784e8097131b27ccd9c6626a7dc404c
https://pubmed.ncbi.nlm.nih.gov/17436088
https://pubmed.ncbi.nlm.nih.gov/17436088
Publikováno v:
Urology. 57(2)
Objectives. To asses the efficacy and safety of Topiglan (1% alprostadil in a formulation with 5% SEPA [soft enhancer of percutaneous absorption]) or placebo gel (0.25 mL) applied to the glans penis only in 60 patients with moderate to severe erectil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4b0e7f2d5e9ca8965e6db4ab574809d
https://pubmed.ncbi.nlm.nih.gov/11182341
https://pubmed.ncbi.nlm.nih.gov/11182341
Autor:
Paul J. Schechter, Kailash C. Bhol
Publikováno v:
American Journal of Gastroenterology. 101:S420-S421
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d9e44794ed8af4af6515305cba27363
https://doi.org/10.14309/00000434-200609001-01070
https://doi.org/10.14309/00000434-200609001-01070
Autor:
Antoni A. Piergies, Wojciech Piekoszewski, Mark S. Shaefer, William J. Jusko, Qais A. Mekki, Goran B. Klintmalm, Paul J. Schechter, Charles C. Lee, Mary F. Hebert
Publikováno v:
Clinical pharmacology and therapeutics. 57(3)
Objective: To characterize the pharmacokinetics of the imnnunosuppressive agent tacrolimus (FK 506) in liver transplant patients. Methods: Patients (n=16) were assessed during and after 1- to 3-day intravenous infusions followed by a 2-week course of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf1b396a916a9c69f5645d8e01b2d802
https://pubmed.ncbi.nlm.nih.gov/7535213
https://pubmed.ncbi.nlm.nih.gov/7535213
Autor:
Sudhir Agrawal, Harout Shahinian, Robert B. Diasio, Zhihong Lu, Jieming Yan, Ruiwen Zhang, Paul J. Schechter, Jamal Temsamani, Zhiwei Jiang, Michael S. Saag, Tiepu Liu, R. Russell Martin, Girish Amin
Publikováno v:
Clinical Pharmacology & Therapeutics. 89:320-320
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1c6538047ee6a6f0ba4a2c427756e73
https://doi.org/10.1038/clpt.2010.272
https://doi.org/10.1038/clpt.2010.272
Autor:
Paul J. Schechter, Albert Sjoerdsma
Publikováno v:
Neurochemical research. 15(4)
Determination of GABA concentrations in human cerebrospinal fluid can be used to assess GABA-ergic activity in the central nervous system. As CSF free GABA concentrations may vary with age, sex, CSF fraction, and collection and storage conditions, ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba0b53a2500c8def9e89183ff971ff74
https://pubmed.ncbi.nlm.nih.gov/2201926
https://pubmed.ncbi.nlm.nih.gov/2201926